Works citing this work

2 works

Work: Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivo

1. Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology

   Jinxin Dong, Denis Nikolenko, Shuxrat Boymuradov +2

   ArticleCAR-T cell therapy researchClinical & Translational Oncology20261 citations

   ABIABI:AkademIndex/openalex/2026.article.000172

2. Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?

   Manh-Cuong Vo, Van-Dinh-Huan Tran, Van‐Tan Nguyen +5

   ArticleCAR-T cell therapy researchJournal of Hematology & Oncology20250 citations

   ABIABI:AkademIndex/openalex/2025.article.000083